Williams Sonoma Inc: Form 10-K for the period ended Jan 29, 2023
Filed with the SEC on Mar 24, 2023 and accepted by EDGAR at Mar 24, 2023, 21:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-01-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-31 to 2023-01-29 | $8.67bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Gross profit | 12 months2022-01-31 to 2023-01-29 | $3.68bn | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2022-01-31 to 2023-01-29 | $2.18bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-01-31 to 2023-01-29 | $1.50bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2022-01-31 to 2023-01-29 | $372.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-31 to 2023-01-29 | $1.13bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-31 to 2023-01-29 | $16.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-31 to 2023-01-29 | $16.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-31 to 2023-01-29 | 69,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-31 to 2023-01-29 | $1.05bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-31 to 2023-01-29 | $354.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-01-31 to 2023-01-29 | $217.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-01-31 to 2023-01-29 | $880.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-01-29 | $367.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-01-29 | $2.04bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-01-29 | $4.66bn | us-gaap:Assets |
| Current liabilities | At period end2023-01-29 | $1.64bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-01-29 | $2.96bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-01-29 | $1.70bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-23-009175. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.